1. WHO Report 2011;Global Tuberculosis Control,2011
2. Tuberculosis Surveillance Report 2009. European Centre for Disease Prevention and Control. Regional Office for Europe,2009
3. Mucosal healing and anti TNFs in IBD;Van Assche;Curr Drug Targets,2010
4. Infliximab approval process in Crohn's disease. Deparment of Health and Human Services. Public Health Service. Food and Drug Administration August 24, 1998.
5. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent;Keane;N Engl J Med,2001